Tag: EMBO-02
Next-generation liquid embolic leads to “substantial” cSDH resolution and functional outcome...
Arsenal Medical has announced late-breaking results from the EMBO-02 clinical study, in which NeoCast—a shear-responsive, solvent-free liquid embolic—was evaluated for middle meningeal artery embolisation...
EMBO-02 study indicates rapid cSDH resorption and pain-free treatments with NeoCast...
Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic...
Arsenal Medical completes enrolment of initial EMBO-02 study cohort
Arsenal Medical has announced the complete enrolment of an initial cohort of 10 patients in the EMBO-02 clinical study evaluating NeoCast for the treatment...
Arsenal Medical launches EMBO-02 study to assess NeoCast in cSDH treatment
Arsenal Medical today announced the initiation of the EMBO-02 clinical study of NeoCast in the treatment of chronic subdural haematomas (cSDHs). NeoCast is a...
